Davis's Drug Guide
DAUNOrubicin citrate liposome
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
**Off Market Drug**
This medication is no longer available in the United States. Information provided here is for reference purposes only.
Pronunciation:
daw-noe-roo-bi-sin sy-trate lye-poe-sohm
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- DaunoXome
Ther. Class.
Pharm. Class.
anthracyclines
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "DAUNOrubicin Citrate Liposome." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Medicine Central, im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/51197/all/DAUNOrubicin_citrate_liposome.
Vallerand AHA, Sanoski CAC, . DAUNOrubicin citrate liposome. Davis's Drug Guide. F.A. Davis Company; 2025. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/51197/all/DAUNOrubicin_citrate_liposome. Accessed April 21, 2025.
Vallerand, A. H., Sanoski, C. A., & , (2025). DAUNOrubicin citrate liposome. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/51197/all/DAUNOrubicin_citrate_liposome
Vallerand AHA, Sanoski CAC, . DAUNOrubicin Citrate Liposome [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 April 21]. Available from: https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/51197/all/DAUNOrubicin_citrate_liposome.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - DAUNOrubicin citrate liposome
ID - 51197
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/51197/all/DAUNOrubicin_citrate_liposome
PB - F.A. Davis Company
ET - 19
DB - Medicine Central
DP - Unbound Medicine
ER -
